Skip to main content

Market Overview

Google Pledges More Than $2.5M For COVID-19 Vaccine Initiatives: Bloomberg

Google Pledges More Than $2.5M For COVID-19 Vaccine Initiatives: Bloomberg
  • Alphabet Inc’s (NASDAQ: GOOG) (NASDAQ: GOOGL) Google has announced $250 million in advertising grants for pro-vaccination groups to sponsor over 2.5 billion vaccine-related public service announcements, Bloomberg reports.
  • Google’s vaccine-focused charity partner, Gavi, will fund 250,000 shots for low and middle-income countries. Google also pledged $2.5 million for pop-up vaccination sites and associated efforts in Black, Latino and rural U.S. communities.
  • The search engine giant has hired former Obama official Karen DeSalvo and other medical experts for a new health division.
  • The company has customized search results for online queries regarding the COVID-19 virus and added vaccination locations in Google Maps.
  • It committed $800 million in pandemic relief for frontline workers and ad credits for health organizations in March 2020.
  • However, Google’s YouTube has faced flak for streaming videos doubting COVID-19 vaccines. Google’s contact-tracing efforts have remained mostly unused by governments.
  • Alphabet health unit, Verily-led COVID-19 testing project concluded in less than a year California.
  • Price action: GOOG shares traded higher by 1.99% at $2,299.73 on the last check Thursday.

Related Articles (GOOG + GOOGL)

View Comments and Join the Discussion!

Posted-In: Bloomberg Briefs Covid-19News Tech Media

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at